Last €69.21 EUR
Change Today +0.75 / 1.10%
Volume 38.7K
As of 1:55 PM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Daniel Camus

Member of Supervisory Board and Chairman of Audit Committee, Morphosys AG
AgeTotal Calculated CompensationThis person is connected to 79 board members in 8 different organizations across 13 different industries.

See Board Relationships
62€62,660

Background*

Dr. Daniel Camus has been a Senior Advisor of Roland Berger Strategy Consultants since June 2011. Dr. Camus served as a Group Senior Executive Vice President of Electricite de France SA from November 2004 to November 18, 2010. He served as a Finance Director of EDF Energy Plc. He served as a General Manager of EDF SA. He served as the Chief Financial Officer of Electricite de France SA from November 2004 to March 29, 2010 and also served as Member of its Management Board. ...

Read Full Background

Corporate Headquarters*

Lena-Christ-Strasse 48
Martinsried, Bavaria 82152

Germany

Phone: 49 8989 9270
Fax: 49 89 8992 7222

Board Members Memberships*

Former Vice Chairman and Member of Executive committee
Vice-Chairman
2005-N/A
Former Director and Chairman of the Audit Committee
2006-Present
Independent Director and Chairman of Audit & Risks Committee
2010-2010
Former Director, Member of Executive Committee and Member of Committee on Nuclear Power
2010-Present
Director
2011-Present
Independent Director, Member of Audit & Finance Committee, Member of Human Resources & Compensation Committee and Member of Safety, Health & Environment Committee

Education*

MBA
Institut D’études Politiques De Paris
PhD
Université de la Sorbonne - Université de Paris

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation€62,660
Total Calculated Compensation€62,660
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MOR:GR €69.21 EUR +0.75

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John W. Varian Chief Executive Officer, President and Director
XOMA Corporation
$489.3K
Leonard Bell M.D.Co-Founder, Chief Executive Officer, Treasurer and Director
Alexion Pharmaceuticals, Inc.
$1.2M
Randal J. Kirk J.D.Chairman, Chief Executive Officer and President
Intrexon Corporation
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MORPHOSYS AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.